4.000
+2,56%
2026-10-19
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +205.8% | +179.3% | 3 / 3 | +61.7% | -4.17 pp | +16.81 pp | +1.0% | 0.27 | 30.51 | 197 | +61,7% | 7,8 | +149,8% | 30.51 | 4.93 | +518,9% |
| Pts | 12 | 12 | 12 | 12 | 0 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 4.000 (close price on 2026-10-19)EPS (TTM): 131,1
Financial charts
1.Revenue & growth
VND bn197Q2/26
1.Revenue & growth
VND bn197Q2/26
2.Profit & growth
VND bn7,80Q2/26
3.Profit mix (Penman)
VND bn13,3Q2/26
4.Margins & cost structure
%10.2%Q2/26
5.Returns & cash cycle
% · days1.4%Q2/26
6.Earnings quality & cash
VND bn23,5Q2/26
7.Asset structure
VND bn1.689Q2/26
8.Funding & debt health
VND bn · times1.689Q2/26
9.Revenue backlog
VND bn13,4Q2/26
10.Valuation
times · %31,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %99Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26